Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren’s syndrome (secondary Sjögren’s syndrome) focusing on autoimmune rheumatic diseases

References

• Baldini C, Talarico R, Tzioufas AG, Bombardieri S. Classification criteria for Sjogren’s syndrome: a critical review. J Autoimmun 2012;39:9–14.
   PubMed Web of Science ®Google Scholar
• Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S. The complexity of Sjogren’s syndrome: novel aspects on pathogenesis. Immunol Lett 2011;141:1–9.
   PubMed Web of Science ®Google Scholar
• Fisher BA, Brown RM, Bowman SJ, Barone F. A review of salivary gland histopathology in primary Sjogren’s syndrome with a focus on its potential as a clinical trials biomarker. Ann Rheum Dis 2015;74:1645–50.
   PubMed Web of Science ®Google Scholar
• Patel R, Shahane A. The epidemiology of Sjogren’s syndrome. Clin Epidemiol 2014;6:247–55.
   PubMed Web of Science ®Google Scholar
• Johnsen SJ, Brun JG, Goransson LG, Smastuen MC, Johannesen TB, Haldorsen K, et al. Risk of non-Hodgkin’s lymphoma in primary Sjogren’s syndrome: a population-based study. Arthritis Care Res 2013;65:816–21.
   PubMed Web of Science ®Google Scholar
• Theander E, Jacobsson LT. Relationship of Sjogren’s syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am 2008;34:935–47, viii–ix.
   PubMed Web of Science ®Google Scholar
• Anaya J-M, Rojas-Villarraga A, Mantilla RD, Arcos-Burgos M, Sarmiento-Monroy JC. Polyautoimmunity in Sjogren syndrome. Rheum Dis Clin North Am 2016;42:457–72.
   PubMed Web of Science ®Google Scholar
• Amador-Patarroyo MJ, Arbelaez JG, Mantilla RD, Rodriguez-Rodriguez A, Cárdenas-Roldán J, Pineda-Tamayo R, et al. Sjogren’s syndrome at the crossroad of polyautoimmunity. J Autoimmun 2012;39:199–205.
   PubMed Web of Science ®Google Scholar
• Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA. Epidemiology of primary Sjogren’s syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) 2006;45:187–91.
   PubMed Web of Science ®Google Scholar
• Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M, et al. Epidemiology of primary Sjogren’s syndrome in a French multiracial/multiethnic area. Arthritis Care Res 2014;66:454–63.
   PubMed Web of Science ®Google Scholar
• Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, et al. Epidemiology of primary Sjogren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 2015;74:1983–9.
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554–8.
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjogren’s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340–7.
   PubMed Web of Science ®Google Scholar
• Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 2017;76:9–16.
   PubMed Web of Science ®Google Scholar
• Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 2017;69:35–45.
   PubMed Web of Science ®Google Scholar
• Turesson C, O’Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:722–7.
   PubMed Web of Science ®Google Scholar
• Calgüneri M, Ureten K, Akif Oztürk M, Onat AM, Ertenli I, Kiraz S, et al. Extra-articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey. Clin Exp Rheumatol 2006;24:305–8.
   PubMed Web of Science ®Google Scholar
• Drosos AA, Lanchbury JS, Panayi GS, Moutsopoulos HM. Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic, and serologic study. Arthritis Rheum 1992;35:745–8.
   PubMed Web of Science ®Google Scholar
• Carmona L, González-Alvaro I, Balsa A, Angel Belmonte M, Tena X, Sanmartí R. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis 2003;62:897–900.
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Tarassi K, Papadopoulos IA, Voulgari PV, Boki KA, Papasteriades CA, et al. Shared epitopes and rheumatoid arthritis: disease associations in Greece and meta-analysis of Mediterranean European populations. Semin Arthritis Rheum 2002;31:361–70.
   PubMed Web of Science ®Google Scholar
• Haga H-J, Naderi Y, Moreno AM, Peen E. A study of the prevalence of sicca symptoms and secondary Sjogren’s syndrome in patients with rheumatoid arthritis, and its association to disease activity and treatment profile. Int J Rheum Dis 2012;15:284–8.
   PubMed Web of Science ®Google Scholar
• Uhlig T, Kvien TK, Jensen JL, Axéll T. Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis. Ann Rheum Dis 1999;58:415–22.
   PubMed Web of Science ®Google Scholar
• Andonopoulos AP, Drosos AA, Skopouli FN, Acritidis NC, Moutsopoulos HM. Secondary Sjogren’s syndrome in rheumatoid arthritis. J Rheumatol 1987;14:1098–103.
   PubMed Web of Science ®Google Scholar
• Mattey DL, González-Gay MA, Hajeer AH, Dababneh A, Thomson W, García-Porrúa C, et al. Association between HLA-DRB1*15 and secondary Sjogren’s syndrome in patients with rheumatoid arthritis. J Rheumatol 2000;27:2611–16.
   PubMed Web of Science ®Google Scholar
• Antero DC, Parra AG, Miyazaki FH, Gehlen M, Skare TL. Secondary Sjogren’s syndrome and disease activity of rheumatoid arthritis. Rev Assoc Med Bras 2011;57:319–22.
   PubMed Web of Science ®Google Scholar
• Kosrirukvongs P, Ngowyutagon P, Pusuwan P, Koolvisoot A, Nilganuwong S. Prevalence of dry eye syndrome and Sjogren’s syndrome in patients with rheumatoid arthritis. J Med Assoc Thai 2012;95(Suppl 4):S61–9.
   Google Scholar
• He J, Ding Y, Feng M, Guo J, Sun X, Zhao J, et al. Characteristics of Sjogren’s syndrome in rheumatoid arthritis. Rheumatology (Oxford) 2013;52:1084–9.
   PubMed Web of Science ®Google Scholar
• Abdelghani KB, Mahmoud I, Chatelus E, Sordet C, Gottenberg JE, Sibilia J. Clinical and serological features of Sjogren syndrome in patients with rheumatoid arthritis. Br J Med Med Res 2015;5:1287–93.
   Google Scholar
• Young A, Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:907–27.
   PubMed Web of Science ®Google Scholar
• Fujita M, Igarashi T, Kurai T, Sakane M, Yoshino S, Takahashi H. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol 2005;140:808–13.
   PubMed Web of Science ®Google Scholar
• Martínez Castro E, Olivé Marqués A, Bonet Llorach M, Carbonell Abellò J, Cobo Valeri E, Juncà Valdor S. [Rheumatoid arthritis and Sjogren’s syndrome. Special reference to the course time of rheumatoid arthritis], in Spanish. Med Clin (Barc) 1990;94:655–9.
   PubMed Web of Science ®Google Scholar
• Aliko A, Ciancaglini R, Alushi A, Tafaj A. Sicca symptoms, and lacrimal and salivary flow in Albanian patients with rheumatoid arthritis. J Oral Pathol Med 2010;39:651–6.
   PubMed Web of Science ®Google Scholar
• Cimmino MA, Salvarani C, Macchioni P, Montecucco C, Fossaluzza V, Mascia MT, et al. Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int 2000;19:213–17.
   PubMed Web of Science ®Google Scholar
• Prabu A, Marshall T, Gordon C, Plant T, Bawendi A, Heaton S, et al. Use of patient age and anti-Ro/La antibody status to determine the probability of patients with systemic lupus erythematosus and sicca symptoms fulfilling criteria for secondary Sjogren’s syndrome. Rheumatology (Oxford) 2003;42:189–91.
   PubMed Web of Science ®Google Scholar
• McDonagh JE, Isenberg DA. Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann Rheum Dis 2000;59:230–2.
   PubMed Web of Science ®Google Scholar
• Manoussakis MN, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli FN, et al. Sjogren’s syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjogren’s syndrome. Arthritis Rheum 2004;50:882–91.
   PubMed Web of Science ®Google Scholar
• Gilboe IM, Kvien TK, Uhlig T, Husby G. Sicca symptoms and secondary Sjogren’s syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables. Ann Rheum Dis 2001;60:1103–9.
   PubMed Web of Science ®Google Scholar
• Alonso MD, Martínez-Vázquez F, Riancho-Zarrabeitia L, Díaz De Terán T, Miranda-Filloy JA, Blanco R, et al. Sex differences in patients with systemic lupus erythematosus from Northwest Spain. Rheumatol Int 2014;34:11–24.
   PubMed Web of Science ®Google Scholar
• Pan HF, Ye DQ, Wang Q, Li WX, Zhang N, Li XP, et al. Clinical and laboratory profiles of systemic lupus erythematosus associated with Sjogren syndrome in China: a study of 542 patients. Clin Rheumatol 2008;27:339–43.
   PubMed Web of Science ®Google Scholar
• Lockshin MD, Levine AB, Erkan D. Patients with overlap autoimmune disease differ from those with ‘pure’ disease. Lupus Sci Med 2015;2:e000084.
   PubMedGoogle Scholar
• Aggarwal R, Anaya JM, Koelsch KA, Kurien BT, Scofield RH. Association between secondary and primary Sjogren’s syndrome in a large collection of lupus families. Autoimm Dis 2015;2015:298506.
   PubMedGoogle Scholar
• Szanto A, Szodoray P, Kiss E, Kapitany A, Szegedi G, Zeher M. Clinical, serologic, and genetic profiles of patients with associated Sjogren’s syndrome and systemic lupus erythematosus. Hum Immunol 2006;67:924–30.
   PubMed Web of Science ®Google Scholar
• Koskenmies S, Järvinen TM, Onkamo P, Panelius J, Tuovinen U, Hasan T, et al. Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations. Lupus 2008;17:337–47.
   PubMed Web of Science ®Google Scholar
• Baer AN, Maynard JW, Shaikh F, Magder LS, Petri M. Secondary Sjogren’s syndrome in systemic lupus erythematosus defines a distinct disease subset. J Rheumatol 2010;37:1143–9.
   PubMed Web of Science ®Google Scholar
• Nossent JC, Swaak AJ. Systemic lupus erythematosus VII: frequency and impact of secondary Sjogren’s syndrome. Lupus 1998;7:231–4.
   PubMed Web of Science ®Google Scholar
• Scofield RH, Bruner GR, Harley JB, Namjou B. Autoimmune thyroid disease is associated with a diagnosis of secondary Sjogren’s syndrome in familial systemic lupus. Ann Rheum Dis 2007;66:410–13.
   PubMed Web of Science ®Google Scholar
• Osial TA Jr., Whiteside TL, Buckingham RB, Singh G, Barnes EL, Pierce JM, et al. Clinical and serologic study of Sjogren’s syndrome in patients with progressive systemic sclerosis. Arthritis Rheum 1983;26:500–8.
   PubMed Web of Science ®Google Scholar
• Drosos AA, Andonopoulos AP, Costopoulos JS, Stavropoulos ED, Papadimitriou CS, Moutsopoulos HM. Sjogren’s syndrome in progressive systemic sclerosis. J Rheum 1988;15:965–8.
   PubMed Web of Science ®Google Scholar
• Drosos AA, Pennec YL, Elisaf M, Lamour A, Acritidis NC, Jouquan JR, et al. Sjogren’s syndrome in patients with the CREST variant of progressive systemic scleroderma. J Rheumatol 1991;18:1685–8.
   PubMed Web of Science ®Google Scholar
• Avouac J, Sordet C, Depinay C, Ardizonne M, Vacher-Lavenu MC, Sibilia J, et al. Systemic sclerosis-associated Sjogren’s syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum 2006;54:2243–9.
   PubMed Web of Science ®Google Scholar
• Salliot C, Mouthon L, Ardizzone M, Sibilia J, Guillevin L, Gottenberg J-E, et al. Sjogren’s syndrome is associated with and not secondary to systemic sclerosis. Rheumatology (Oxford) 2007;46:321–6.
   PubMed Web of Science ®Google Scholar
• Kobak S, Oksel F, Aksu K, Kabasakal Y. The frequency of sicca symptoms and Sjogren’s syndrome in patients with systemic sclerosis. Int J Rheum Dis 2013;16:88–92.
   PubMed Web of Science ®Google Scholar
• Rojana-Udomsart A, Needham M, Luo YB, Fabian V, Walters S, Zilko PJ, et al. The association of sporadic inclusion body myositis and Sjogren’s syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype. Clin Neurol Neurosurg 2011;113:559–63.
   PubMed Web of Science ®Google Scholar
• Váncsa A, Gergely L, Ponyi A, Lakos G, Németh J, Szodoray P, et al. Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: relevance for clinical classification: retrospective study of 169 patients. Joint Bone Spine 2010;77:125–30.
   PubMed Web of Science ®Google Scholar
• Dobloug GC, Antal EA, Sveberg L, Garen T, Bitter H, Stjärne J, et al. High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study. Eur J Neurol 2015;22:672–e41.
   PubMed Web of Science ®Google Scholar
• Brown LE, Frits ML, Iannaccone CK, Weinblatt ME, Shadick NA, Liao KP. Clinical characteristics of RA patients with secondary SS and association with joint damage. Rheumatology (Oxford) 2015;54:816–20.
   PubMed Web of Science ®Google Scholar
• Baldini C, Mosca M, Della Rossa A, Pepe P, Notarstefano C, Ferro F, et al. Overlap of ACA-positive systemic sclerosis and Sjogren’s syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma. Clin Exp Rheum 2013;31:272–80.
   PubMed Web of Science ®Google Scholar
• Martens PB, Pillemer SR, Jacobsson LT, O’Fallon WM, Matteson EL. Survivorship in a population based cohort of patients with Sjögren's syndrome, 1976–1992. J Rheumatol 1999;26:1296–300.
   PubMed Web of Science ®Google Scholar
• Kauppi M, Pukkala E, Isomäki H. Elevated incidence of hematologic malignancies in patients with Sjogren’s syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control 1997;8:201–4.
   PubMed Web of Science ®Google Scholar
• Koszarny A, Majdan M, Dryglewska M, Tabarkiewicz J. Prevalence of selected organ-specific autoantibodies in rheumatoid arthritis and primary Sjogren’s syndrome patients. Reumatologia 2015;53:61–8.
   PubMedGoogle Scholar
• Hernández-Molina G, Avila-Casado C, Cárdenas-Velázquez F, Hernández-Hernández C, Calderillo ML, Marroquín V, et al. Similarities and differences between primary and secondary Sjogren’s syndrome. J Rheumatol 2010;37:800–8.
   PubMed Web of Science ®Google Scholar
• Streckfus C, Bigler L, Navazesh M, Al-Hashimi I. Cytokine concentrations in stimulated whole saliva among patients with primary Sjogren’s syndrome, secondary Sjogren’s syndrome, and patients with primary Sjogren’s syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study. Clin Oral Invest 2001;5:133–5.
   PubMedGoogle Scholar
• Tishler M, Aharon A, Ehrenfeld M, Avni I, Bendet E, Bombardieri S, et al. Sjogren’s syndrome in Israel: primary versus secondary disease. Clin Rheum 1994;13:438–41.
   PubMed Web of Science ®Google Scholar
• Andonopoulos AP, Skopouli FN, Dimou GS, Drosos AA, Moutsopoulos HM. Sjogren’s syndrome in systemic lupus erythematosus. J Rheumatol 1990;17:201–4.
   PubMed Web of Science ®Google Scholar